Flagship explainer
What drives SONOMA PHARMACEUTICALS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$3.2M | FY2026 |
| |
| Income before tax | −$3.4M | FY2026 |
|
| Operating income | −$2.5M | FY2026 |
|
| $19.5M | FY2026 |
| |
| Ending assets | $14M | FY2026 |
|
| Beginning assets | $13.7M | FY2025 |
|
| $3.1M | FY2026 |
| |
| $4.4M | FY2025 |
|
Source:
- SEC filingFiling detailsAccession 0001683168-25-004546
- SEC filingFiling detailsAccession 0001683168-26-004871